KFDA to review 911 drugs including 61 GSK products.

Published: 2005-10-18 06:59:00

Updated: 2005-10-18 06:59:00

The KFDA reported in "The status of new drugs and others to review" that the total 911 drugs should be reviewed, of which GSK had the highest number of products including Avandia, an anti-diabetic drug, among the foreign multinational drug companies and Dong-A and Choongwae among the domestic ind...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK